HIV co-infection in HTLV-1 carriers in Spain.


Por: de Mendoza C, Caballero E, Aguilera A, Benito R, Maciá D, García-Costa J, Soriano V and Spanish HTLV Network

Publicada: 1 jun 2019 Ahead of Print: 15 abr 2019
Resumen:
BACKGROUND: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. In contrast, HTLV-1 is not endemic in Spain, despite hosting huge numbers of migrants from highly endemic regions. Herein, we report the rate and main features of the HIV-HTLV co-infected population in Spain. METHODS: A national registry exists in Spain for HTLV since year 1989. Data from standardized case report forms and one centralized lab repository were reviewed, especially for the subset with HTLV-HIV co-infection. RESULTS: Up to December 2018, a total of 369 individuals with HTLV-1 had been diagnosed in Spain. 64% of the population were females, and Latin American individuals accounted for 64.5%. Classical HTLV-associated illnesses were found in 12.7% (myelopathy) and 7.6% (leukemia). HIV coinfection was found in 12 (3.2%). Of those, 3 patients (25%) were female and 39 (75%) were of non-Spanish origin. All but two harbored HIV-1 subtype B, being non-B variants found in the two West Africans. Exposure had been sexual in most cases, being 4 homosexual men. Seven HTLV-HIV co-infected patients had developed AIDS and two had developed myelopathy. There was no evidence for increased HTLV-1 clinical pathogenicity due to HIV coinfection. CONCLUSION: HIV coinfection is infrequent (<5%) among HTLV-1 carriers in Spain. More than half of co-infected patients come from Latin America. Sexual contact is the most frequent risk behavior, being MSM one third of cases. Late diagnosis explains the high rate (9/12) of clinical manifestations in our HIV-HTLV co-infected population.

Filiaciones:
de Mendoza C:
 Puerta de Hierro Research Institute & University Hospital, Madrid, Spain

 Microbiology Department, CEU-San Pablo University, Madrid, Spain

Caballero E:
 Hospital Vall d'Hebron, Barcelona, Spain

Aguilera A:
 Complexo Hospitalario Universitario, Santiago, Spain

Benito R:
 Hospital Clínico Lozano Blesa, Zaragoza, Spain

Maciá D:
 Hospital Son Llatzer, Mallorca, Spain

García-Costa J:
 Complejo Hospitalario Universitario, Orense, Spain

Soriano V:
 UNIR Health Sciences School & Medical Center, Madrid, Spain
ISSN: 01681702





VIRUS RESEARCH
Editorial
Elsevier BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 266 Número:
Páginas: 48-51
WOS Id: 000468256000006
ID de PubMed: 30998953

MÉTRICAS